NVNO logo

NVNO

enVVeno Medical Corporation

$0.33
+$0.01(+1.67%)
46
Overall
60
Value
33
Tech
--
Quality
Market Cap
$13.75M
Volume
409.00K
52W Range
$0.30 - $5.62
Target Price
$12.50

Company Overview

Mkt Cap$13.75MPrice$0.33
Volume409.00KChange+1.67%
P/E Ratio-0.6Open$0.32
Revenue--Prev Close$0.32
Net Income$-21.8M52W Range$0.30 - $5.62
Div YieldN/ATarget$12.50
Overall46Value60
Quality--Technical33

No chart data available

About enVVeno Medical Corporation

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing

Latest News

enVVeno Medical Amends Quorum Requirement for Meetings

enVVeno Medical ( ($NVNO) ) has provided an announcement. On November 17, 2025, enVVeno Medical Corporation’s Board of Directors approved an amendm...

TipRanks Auto-Generated Newsdesk2 days ago
ABCD
1SymbolPriceChangeVol
2NVNO$0.33+1.7%409.00K
3
4
5
6

Get enVVeno Medical Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.